These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 31198088)
1. Domain-specific cognitive effects of white matter pathology in old age, mild cognitive impairment and Alzheimer's disease. Kaskikallio A; Karrasch M; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 May; 27(3):453-470. PubMed ID: 31198088 [TBL] [Abstract][Full Text] [Related]
2. White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study. Kaskikallio A; Karrasch M; Koikkalainen J; Lötjönen J; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P Dement Geriatr Cogn Disord; 2019; 48(5-6):297-307. PubMed ID: 32209796 [TBL] [Abstract][Full Text] [Related]
3. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease. Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116 [TBL] [Abstract][Full Text] [Related]
4. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters. Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN; Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760 [TBL] [Abstract][Full Text] [Related]
5. Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease. Wang J; Wang P; Jiang Y; Wang Z; Zhang H; Li H; Biswal BB J Alzheimers Dis; 2022; 85(4):1795-1806. PubMed ID: 34958033 [TBL] [Abstract][Full Text] [Related]
6. Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease. Defrancesco M; Egger K; Marksteiner J; Esterhammer R; Hinterhuber H; Deisenhammer EA; Schocke M PLoS One; 2014; 9(8):e106062. PubMed ID: 25153085 [TBL] [Abstract][Full Text] [Related]
7. Quantitative T2 mapping of white matter: applications for ageing and cognitive decline. Knight MJ; McCann B; Tsivos D; Dillon S; Coulthard E; Kauppinen RA Phys Med Biol; 2016 Aug; 61(15):5587-605. PubMed ID: 27384985 [TBL] [Abstract][Full Text] [Related]
8. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition. Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799 [TBL] [Abstract][Full Text] [Related]
9. Cognitive Effects of White Matter Pathology in Normal and Pathological Aging. Kaskikallio A; Karrasch M; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P J Alzheimers Dis; 2019; 67(2):489-493. PubMed ID: 30594927 [TBL] [Abstract][Full Text] [Related]
10. Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging. van Es AC; van der Flier WM; Admiraal-Behloul F; Olofsen H; Bollen EL; Middelkoop HA; Weverling-Rijnsburger AW; van der Grond J; Westendorp RG; van Buchem MA AJNR Am J Neuroradiol; 2007; 28(10):1938-42. PubMed ID: 17925378 [TBL] [Abstract][Full Text] [Related]
11. Microstructural white matter abnormalities independent of white matter lesion burden in amnestic mild cognitive impairment and early Alzheimer disease among Han Chinese elderly. Liao J; Zhu Y; Zhang M; Yuan H; Su MY; Yu X; Wang H Alzheimer Dis Assoc Disord; 2010; 24(4):317-24. PubMed ID: 20592582 [TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia. Dadar M; Manera AL; Ducharme S; Collins DL Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832 [TBL] [Abstract][Full Text] [Related]
13. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment. Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694 [TBL] [Abstract][Full Text] [Related]
14. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138 [TBL] [Abstract][Full Text] [Related]
15. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment. Low A; Ng KP; Chander RJ; Wong B; Kandiah N J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121 [TBL] [Abstract][Full Text] [Related]
16. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease. Kumar A; Singh S; Verma A; Mishra VN Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488 [TBL] [Abstract][Full Text] [Related]
17. Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts. Grambaite R; Selnes P; Reinvang I; Aarsland D; Hessen E; Gjerstad L; Fladby T J Alzheimers Dis; 2011; 27(2):453-62. PubMed ID: 21841261 [TBL] [Abstract][Full Text] [Related]